Could a gut bacteria transplant help control type 1 diabetes?

NCT ID NCT06256614

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study is testing whether transplanting gut bacteria from healthy donors into people with type 1 diabetes can help control blood sugar and reduce insulin needs. Fifty participants will receive three doses of washed microbiota through the gastrointestinal tract. Researchers will track daily insulin use and time spent in target blood sugar range to see if the treatment is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
washed microbiota from healthy donors
What this could lead to
If it works, this could offer a new way to help manage type 1 diabetes by improving blood sugar control and reducing the amount of insulin needed.
What could go wrong
This is a small, early real-world study with only 50 participants, so results may not apply to everyone. The treatment involves infusing donor bacteria into the gut, which carries unknown risks and may not provide lasting benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

    RECRUITING

    Nanjing, Jiangsu, 210011, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.